Coagulation Market Research Reports & Industry Analysis
Coagulation factors have been implicated as independent factors in the development of myocardial infarction, stroke and deep vein thrombosis in some patients. With the increasing incidence of cardiovascular diseases, this discovery has brought what was a rather lackluster discipline into the limelight. The intensive investigation of coagulation processes has uncovered a number of other conditions in which coagulation factors are implicated, such as: post surgical bleeding due to the use of aspirin or Plavix, spontaneous abortion and pregnancy problems.
Demand for rapid decentralized coagulation testing is increasing. The number of patients needing coagulation testing is growing. More patients are using anticoagulants following implantation of mechanical heart valves or after atrial fibrillation. More recently patients are using antithrombotic agents after, or to prevent, deep venous thrombosis, arterial or pulmonary embolism, stroke, angina pectoris, and myocardial infarction. There is also increasing pressure to return results to clinicians rapidly so that anticoagulant therapy can be adjusted.
Coagulation Industry Research & Market Reports
-
Coagulation Analyzers Market Insights, Competitive Landscape and Market Forecast–2026
... Testing, Platelet Function Testing, Others), By Technology (Optical Technology, Mechanical Technology, Electrochemical Technology, Others), By End-User (Hospitals, Diagnostic Centers, And Others), And By Geography is anticipated to grow at a significant CAGR forecast till 2026 ... Read More
-
Clinical Laboratory Service Markets, 6th Edition
... diseases in the U.S. and worldwide demographics, life expectancy, and company strategies. Information is presented as a global focused market report, with key regions discussed including: North America (United States, Canada) Europe, Middle East, and ... Read More
-
IVD Procedure Volumes 2020-2025: Immunoassays, POC, Chemistry, Molecular, Microbiology and Other Tests
... glucose monitoring activities will account for approximately 76% of testing volume and about $20 billion of product sales. Excluding blood glucose tests, global IVD procedural volume is forecast to rise 4.0% annually to 28.8 billion ... Read More
-
Hematology and Coagulation Markets (Lab-based and Decentralized Markets)
... bone marrow cells in order to diagnose various diseases of the blood including leukemias, anemia and autoimmune diseases. The menu of hematology tests includes: CBC + 5-part differential (or 3-part differential), manual differential/review, hematocrit, hemoglobin ... Read More
-
The Worldwide Market for Point-of-Care (POC) Diagnostics, 7th Edition (Infectious Disease Testing, POC Cancer Tests, Rapid Coagulation, Urine Testing, Lipid Tests, Pregnancy Testing, Glucose Testing and Other POC)
... a fast-growing and competitive category of the in vitro diagnostic market. Point-of-care (POC) tests are diagnostics performed outside the central laboratory or executed via decentralized testing. POC testing has skyrocketed in the last 20 years ... Read More
-
The World Market for Biomarkers (Cardiac Markers [cTn, HscTn, Acute CK-MB/BNP, Others], Tumor Markers [PSA, CEA, CA 125, AFP, PSA Rapid, Others], Coagulation Markers [PT/INR, D-dimer], Infectious Disease Markers [by Disease], Immunological Disease Markers [Autoimmune/Allergy], Neurological Markers, C-Reactive Protein and Other Markers)
... Markers, C-Reactive Protein and Other Markers) Biomarkers are biological or biochemical molecules, genetic changes, or other characteristics that can be measured; they indicate or predict a condition, risk, or likely biological response. Biomarkers can be ... Read More
Research Assistance
